JOHNSON & JOHNSON is 47.4x more valuable than IONIS PHARMACEUTICALS INC by market capitalization ($574.10 B vs $12.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IONS | JNJ |
|---|---|---|
| Market cap | $12.12 B | $574.10 B |
| US-listed rank | #835 | #20 |
| Revenue (latest FY) | $943.71M | $94.19B |
| Net income (latest FY) | -$381.39M | $26.80B |
| Net margin | -40.4% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 2,623 | 984 |
JOHNSON & JOHNSON is 47.4x more valuable than IONIS PHARMACEUTICALS INC by market capitalization ($574.10 B vs $12.12 B).
In their latest fiscal years, IONIS PHARMACEUTICALS INC reported $943.71M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: IONIS PHARMACEUTICALS INC and JOHNSON & JOHNSON, or browse the full rankings.